Pharmacogenomic testing could help reduce adverse drug reactions in the UK
7 Articles
7 Articles
Pharmacogenomic testing could help reduce adverse drug reactions in the UK
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on patient's genes.


Gene Tests Could Prevent Avoidable Adverse Drug Reactions
A UK study found that nearly 1 in 10 adverse drug reactions involve medications influenced by genetic factors, highlighting the need for wider testing. Medscape News UK


Revolutionary Gene Testing Could Prevent 75% of Avoidable Medication Side
A pivotal new study from Queen Mary University of London highlights an alarming trend: around 9% of all reported adverse drug reactions (ADRs) submitted to the UK medicines regulator can be linked to medications whose side effect risks are influenced by a patient’s genetic makeup. The findings emphasize the urgent need for preemptive genetic testing prior to medication prescription, potentially leading to safer and more effective healthcare mana…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage